Tomasso, Annamaria
 Distribuzione geografica
Continente #
NA - Nord America 197
EU - Europa 147
AS - Asia 12
AF - Africa 1
SA - Sud America 1
Totale 358
Nazione #
US - Stati Uniti d'America 197
IT - Italia 54
SE - Svezia 35
IE - Irlanda 19
DE - Germania 15
CN - Cina 7
FR - Francia 6
CZ - Repubblica Ceca 5
FI - Finlandia 3
IN - India 3
NL - Olanda 3
UA - Ucraina 2
BR - Brasile 1
CI - Costa d'Avorio 1
ES - Italia 1
GB - Regno Unito 1
IL - Israele 1
IR - Iran 1
MC - Monaco 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 358
Città #
Chandler 66
Ashburn 24
Dublin 19
Florence 15
Milan 12
Rome 9
Bremen 8
Princeton 8
Beijing 6
Boston 6
Marseille 6
New York 6
North Hollywood 5
Brdo 4
Pavia 4
Pune 3
San Marzano sul Sarno 3
San Mateo 3
Washington 3
Amsterdam 2
Garden City 2
Helsinki 2
Napoli 2
Seattle 2
Wilmington 2
Abidjan 1
Berlin 1
Brno 1
Fairfield 1
Hefei 1
Lappeenranta 1
London 1
Los Angeles 1
Monaco 1
Norwalk 1
Nuremberg 1
San Giovanni Teatino 1
Stockholm 1
Vinhedo 1
Warsaw 1
Zanjan 1
Totale 238
Nome #
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 55
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 41
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 41
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 40
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 37
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 29
Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia 29
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 26
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 19
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 19
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 16
Richter transformation in Chronic Lymphocytic Leukemia 15
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 10
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 2
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 1
Totale 380
Categoria #
all - tutte 2.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 1 1
2021/202255 0 0 5 1 3 0 0 4 2 0 26 14
2022/2023186 26 23 8 26 18 18 7 14 23 6 17 0
2023/2024137 6 36 11 15 13 29 10 2 0 14 1 0
Totale 380